← Leaderboards
Shuyuan Yeh
University Of Rochester
$4,966,620
Attributed
$7,269,674
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2007–15$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$7,269,674 · 5
By mechanism
R01$7,269,674 · 5
Top collaborators
- Chawnshang Chang15 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Chawnshang Chang$14,165,223
- Xinping Zhang$9,135,393
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateProstateStromal CellsPlayLeadEpithelial CellsAndrogensTumor ProgressionGrowthMouse ModelEpithelialKnock-OutAndrogen ReceptorReceptor FunctionProstatic NeoplasmsCancer ModelProstaticHormonesKnockout MiceIn VitroMalignant NeoplasmsCellsIn VivoCessation Of Life
Grant awards (25)
Stromal AR Roles in Prostate Hyperplasia and Cancer$320,588
R01 · FY2015 · CA
Stromal AR Roles in Prostate Hyperplasia and Cancer$310,970
R01 · FY2014 · CA
ERalpha in prostate homeostasis and cancer$73,264
R01 · FY2014 · CA · contact PI
ERalpha in prostate homeostasis and cancer$320,324
R01 · FY2013 · CA · contact PI
Stromal AR Roles in Prostate Hyperplasia and Cancer$301,353
R01 · FY2013 · CA
ERalpha in prostate homeostasis and cancer$328,153
R01 · FY2012 · CA · contact PI
Stromal AR Roles in Prostate Hyperplasia and Cancer$320,588
R01 · FY2012 · CA
New Mice Models for Studies of Androgen Receptor in Prostate Cancer$309,964
R01 · FY2012 · CA
Stromal AR Roles in Prostate Hyperplasia and Cancer$319,810
R01 · FY2011 · CA
New Mice Models for Studies of Androgen Receptor in Prostate Cancer$309,964
R01 · FY2011 · CA
Loss of Androgen Receptor Promotes Metastatic Prostate Cancer$283,822
R01 · FY2011 · CA
ERalpha in prostate homeostasis and cancer$187,953
R01 · FY2011 · CA · contact PI
New Mice Models for Studies of Androgen Receptor in Prostate Cancer$319,550
R01 · FY2010 · CA
ERalpha in prostate homeostasis and cancer$317,821
R01 · FY2010 · CA · contact PI
Loss of Androgen Receptor Promotes Metastatic Prostate Cancer$292,600
R01 · FY2010 · CA
ERalpha in prostate homeostasis and cancer$319,550
R01 · FY2009 · CA · contact PI
New Mice Models for Studies of Androgen Receptor in Prostate Cancer$319,550
R01 · FY2009 · CA
Loss of Androgen Receptor Promotes Metastatic Prostate Cancer$292,600
R01 · FY2009 · CA
New Mice Models for Studies of Androgen Receptor in Prostate Cancer$319,550
R01 · FY2008 · CA
Loss of Androgen Receptor Promotes Metastatic Prostate Cancer$292,600
R01 · FY2008 · CA
Loss of Androgen Receptor Promotes Metastatic Prostate Cancer$292,600
R01 · FY2007 · CA
MAP Kinase Signal on AR and AR coregulators$279,125
R01 · FY2004 · DK
MAP Kinase Signal on AR and AR coregulators$279,125
R01 · FY2003 · DK
MAP Kinase Signal on AR and AR coregulators$279,125
R01 · FY2002 · DK
MAP Kinase Signal on AR and AR coregulators$279,125
R01 · FY2001 · DK